Works matching DE "DOPAMINE agonists"
Results: 1570
Therapeutic Effect of Bromocriptine as a Dopamine Agonist on Endometrioma Size: A Double-Blind Randomized Controlled Trial.
- Published in:
- International Journal of Women's Health & Reproduction Sciences, 2025, v. 13, n. 1, p. 25, doi. 10.15296/ijwhr.2023.27
- By:
- Publication type:
- Article
A Narrative Review of Surgery for Prolactinomas: Considerations and Controversies.
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 4, p. 1089, doi. 10.3390/jcm14041089
- By:
- Publication type:
- Article
Levodopa and dopamine agonist phobia in Parkinson's Disease -- does it really matter? A survey on treatment patterns in Polish tertiary centres.
- Published in:
- Polish Journal of Neurology & Neurosurgery / Neurologia i Neurochirurgia Polska, 2025, v. 59, n. 1, p. 62, doi. 10.5603/pjnns.103168
- By:
- Publication type:
- Article
The cost-effectiveness of early cabergoline treatment compared to levodopa in Sweden.
- Published in:
- European Journal of Health Economics, 2003, v. 4, n. 1, p. 37, doi. 10.1007/s10198-002-0144-3
- By:
- Publication type:
- Article
Management of psychosis in the course of cushing syndrome: a review.
- Published in:
- Drugs & Therapy Perspectives, 2024, v. 40, n. 9, p. 371, doi. 10.1007/s40267-024-01092-7
- By:
- Publication type:
- Article
Screen for drug-induced gambling disorder in vulnerable patients receiving dopaminergic drugs.
- Published in:
- Drugs & Therapy Perspectives, 2023, v. 39, n. 8, p. 297, doi. 10.1007/s40267-023-01015-y
- By:
- Publication type:
- Article
Vitex Agnus-Castus for the Treatment of Cyclic Mastalgia: A Systematic Review and Meta-Analysis.
- Published in:
- Journal of Women's Health (15409996), 2020, v. 29, n. 2, p. 262, doi. 10.1089/jwh.2019.7770
- By:
- Publication type:
- Article
Characteristics and outcomes of men with erectile dysfunction as the presenting symptom due to a lactotroph adenoma.
- Published in:
- Acta Neurochirurgica, 2024, v. 166, n. 1, p. 1, doi. 10.1007/s00701-024-06213-9
- By:
- Publication type:
- Article
The Non-Ergot Derived Dopamine Agonist Quinagolide as an Anti-Endometriotic Agent.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Age-related decrease in the opioid control of LH secretion during reproductive years in normal women.
- Published in:
- 1997
- By:
- Publication type:
- journal article
Differential Contributions of Dopamine D<sub>1</sub>, D<sub>2</sub>, and D<sub>3</sub> Receptors to MDMA-Induced Effects on Locomotor Behavior Patterns in Mice.
- Published in:
- Neuropsychopharmacology, 2006, v. 31, n. 11, p. 2349, doi. 10.1038/sj.npp.1301161
- By:
- Publication type:
- Article
Aripiprazole Attenuates the Discriminative-Stimulus and Subject-Rated Effects of D-Amphetamine in Humans.
- Published in:
- Neuropsychopharmacology, 2005, v. 30, n. 11, p. 2103, doi. 10.1038/sj.npp.1300803
- By:
- Publication type:
- Article
SSR181507, A Dopamine D<sub>2</sub> Receptor Antagonist and 5-HT<sub>1A</sub> Receptor Agonist. II: Behavioral Profile Predictive of an Atypical Antipsychotic Activity.
- Published in:
- Neuropsychopharmacology, 2003, v. 28, n. 11, p. 1889, doi. 10.1038/sj.npp.1300261
- By:
- Publication type:
- Article
Chronic Pubertal, but not Adult Chronic Cannabinoid Treatment Impairs Sensorimotor Gating, Recognition Memory, and the Performance in a Progressive Ratio Task in Adult Rats.
- Published in:
- Neuropsychopharmacology, 2003, v. 28, n. 10, p. 1760, doi. 10.1038/sj.npp.1300225
- By:
- Publication type:
- Article
Cocaine-Seeking Behavior in Response to Drug-Associated Stimuli in Rats: Involvement of D<sub>3</sub> and D<sub>2</sub> Dopamine Receptors.
- Published in:
- Neuropsychopharmacology, 2003, v. 28, n. 6, p. 1150, doi. 10.1038/sj.npp.1300169
- By:
- Publication type:
- Article
The Muscarinic M<sub>1</sub>/M<sub>4</sub> Receptor Agonist Xanomeline Exhibits Antipsychotic-Like Activity in Cebus apella Monkeys.
- Published in:
- Neuropsychopharmacology, 2003, v. 28, n. 6, p. 1168, doi. 10.1038/sj.npp.1300151
- By:
- Publication type:
- Article
Sensitivity to Sensorimotor Gating-Disruptive Effects of Apomorphine in two Outbred Parental Rat Strains and their F1 and N2 Progeny.
- Published in:
- Neuropsychopharmacology, 2003, v. 28, n. 2, p. 226, doi. 10.1038/sj.npp.1300035
- By:
- Publication type:
- Article
The effects of endophyte-infected tall fescue consumption and use of a dopamine antagonist on intake, digestibility, body temperature, and blood constituents in sheep.
- Published in:
- Journal of Animal Science, 1993, v. 71, n. 1, p. 158, doi. 10.2527/1993.711158x
- Publication type:
- Article
Quantitative structure activity relationships (QSAR) of substituded ( S )-phenylpiperidines as preferential dopamine autoreceptor antagonists.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2005, v. 20, n. 1, p. 5, doi. 10.1080/14756360400002023
- By:
- Publication type:
- Article
Restless legs syndrome in DNAJC12 deficiency.
- Published in:
- Neurological Sciences, 2023, v. 44, n. 6, p. 2167, doi. 10.1007/s10072-023-06733-9
- By:
- Publication type:
- Article
Screening for impulse control disorders in Parkinson's disease and dopamine agonist use: a study of pharmacokinetic and psychological risk factors.
- Published in:
- Neurological Sciences, 2023, v. 44, n. 2, p. 565, doi. 10.1007/s10072-022-06485-y
- By:
- Publication type:
- Article
A meta-analysis evaluating effects of the rotigotine in Parkinson's disease, focusing on sleep disturbances and activities of daily living.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Levodopa-carbidopa intestinal gel is an option in Parkinson's disease with hyponatremia induced by dopamine agonists.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Research advances on L-DOPA-induced dyskinesia: from animal models to human disease.
- Published in:
- Neurological Sciences, 2020, v. 41, n. 8, p. 2055, doi. 10.1007/s10072-020-04333-5
- By:
- Publication type:
- Article
Real life evaluation of safinamide effectiveness in Parkinson's disease.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Caffeine drinking, cigarette smoking, and dopaminergic replacement therapy dose in Parkinson's disease.
- Published in:
- Neurological Sciences, 2013, v. 34, n. 6, p. 979, doi. 10.1007/s10072-012-1180-0
- By:
- Publication type:
- Article
Effect of cabergoline on increase of several ER stress-related molecules in 6-OHDA-lesioned mice.
- Published in:
- 2013
- By:
- Publication type:
- Letter
Surgical Treatment of Prolactinomas - Our Experience.
- Published in:
- Collegium Antropologicum, 2014, v. 38, n. 2, p. 571
- By:
- Publication type:
- Article
Supporting people with Parkinson’s in later life.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Journal scan.
- Published in:
- Nursing Older People, 2014, v. 26, n. 9, p. 13, doi. 10.7748/nop2014.02.26.1.13.s17
- Publication type:
- Article
Periodic leg movements during sleep in PLMD and RLS patients with and without pramipexole treatment.
- Published in:
- Somnologie, 2013, v. 17, n. 4, p. 266, doi. 10.1007/s11818-013-0622-0
- By:
- Publication type:
- Article
Unruhe statt Schlafen.
- Published in:
- Somnologie, 2012, v. 16, n. 1, p. 20, doi. 10.1007/s11818-012-0555-z
- By:
- Publication type:
- Article
Bewältigungs-strategien beim Restless-legs-Syndrom. .
- Published in:
- Somnologie, 2010, v. 14, n. 1, p. 61, doi. 10.1007/s11818-009-0442-4
- By:
- Publication type:
- Article
Exploring the impact of deleterious missense nonsynonymous single nucleotide polymorphisms in the DRD4 gene using computational approaches.
- Published in:
- Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-86916-w
- By:
- Publication type:
- Article
Synthetic aporphine alkaloids are potential therapeutics for Leigh syndrome.
- Published in:
- Scientific Reports, 2024, v. 11, n. 1, p. 1, doi. 10.1038/s41598-024-62445-w
- By:
- Publication type:
- Article
A decision support system based on recurrent neural networks to predict medication dosage for patients with Parkinson's disease.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-59179-0
- By:
- Publication type:
- Article
Long-Term Real-World Experience with Safinamide in Patients with Parkinson's Disease.
- Published in:
- Brain Sciences (2076-3425), 2024, v. 14, n. 12, p. 1238, doi. 10.3390/brainsci14121238
- By:
- Publication type:
- Article
Non-Ergot Dopamine Agonists and the Risk of Heart Failure and Other Adverse Cardiovascular Reactions in Parkinson's Disease.
- Published in:
- Brain Sciences (2076-3425), 2024, v. 14, n. 8, p. 776, doi. 10.3390/brainsci14080776
- By:
- Publication type:
- Article
Quantification of Non-Motor Symptoms in Parkinsonian Cynomolgus Monkeys.
- Published in:
- Brain Sciences (2076-3425), 2023, v. 13, n. 8, p. 1153, doi. 10.3390/brainsci13081153
- By:
- Publication type:
- Article
Application of Antipsychotic Drugs in Mood Disorders.
- Published in:
- Brain Sciences (2076-3425), 2023, v. 13, n. 3, p. 414, doi. 10.3390/brainsci13030414
- By:
- Publication type:
- Article
Altered Pain Processing Associated with Administration of Dopamine Agonist and Antagonist in Healthy Volunteers.
- Published in:
- Brain Sciences (2076-3425), 2022, v. 12, n. 3, p. 351, doi. 10.3390/brainsci12030351
- By:
- Publication type:
- Article
Rasagiline Withdrawal Syndrome in Parkinson's Disease.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Sex Differences in Dopamine Receptor Signaling in Fmr1 Knockout Mice: A Pilot Study.
- Published in:
- Brain Sciences (2076-3425), 2021, v. 11, n. 11, p. 1398, doi. 10.3390/brainsci11111398
- By:
- Publication type:
- Article
Dopamine-Depleted Dopamine Transporter Knockout (DDD) Mice: Dyskinesia with L-DOPA and Dopamine D1 Agonists.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 11, p. 1658, doi. 10.3390/biom13111658
- By:
- Publication type:
- Article
Dopamine D 1 Agonists: First Potential Treatment for Late-Stage Parkinson's Disease.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 5, p. 829, doi. 10.3390/biom13050829
- By:
- Publication type:
- Article
Dopamine D3 Receptor: Contemporary Views of Its Function and Pharmacology for Neuropsychiatric Diseases.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
The α6 GABA A Receptor Positive Allosteric Modulator DK-I-56-1 Reduces Tic-Related Behaviors in Mouse Models of Tourette Syndrome.
- Published in:
- Biomolecules (2218-273X), 2021, v. 11, n. 2, p. 175, doi. 10.3390/biom11020175
- By:
- Publication type:
- Article
Depression in the Elderly. Consensus Statement of the Spanish Psychogeriatric Association.
- Published in:
- Frontiers in Psychiatry, 2020, v. 11, p. 1, doi. 10.3389/fpsyt.2020.00380
- By:
- Publication type:
- Article
A comparison of the effects of amphetamine and low doses of apomorphine on operant force production, interresponse times and response duration in rat.
- Published in:
- Psychopharmacology, 1999, v. 145, n. 4, p. 351, doi. 10.1007/s002130051068
- By:
- Publication type:
- Article
Selective attenuation of the antinociceptive effects of μ opioids by the putative dopamine D[sub 3] agonist 7-OH-DPAT.
- Published in:
- Psychopharmacology, 1999, v. 144, n. 3, p. 239, doi. 10.1007/s002130050999
- By:
- Publication type:
- Article